✨ Medicines Distribution Consents




5270 NEW ZEALAND GAZETTE, No. 207 15 DECEMBER 2005

Dated this 1st day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8343

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Powder for injection
Diluent

New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: MonoFIX-VF
Active Ingredient: Factor IX 1,000IU
Dosage Form: Powder for injection
Diluent

New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia

Product: MonoFIX-VF
Active Ingredient: Factor IX 500IU
Dosage Form: Powder for injection
Diluent

New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia

Dated this 8th day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8345

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Alimta
Active Ingredient: Pemetrexed sodium 713mg equivalent to 500mg pemetrexed
Dosage Form: Powder for infusion

New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Lilly France SAS, Fegersheim, France

Dated this 1st day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8342

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Eloxatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion

New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 207


Gazette.govt.nz PDF NZ Gazette 2005, No 207





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
1 December 2005
Medicines Act, New Medicines, Distribution, Enbrel, Etanercept, MonoFIX-VF, Factor IX
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
1 December 2005
Medicines Act, Changed Medicine, Distribution, Alimta, Pemetrexed sodium
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
1 December 2005
Medicines Act, Changed Medicines, Distribution, Eloxatin, Oxaliplatin
  • DON MATHESON, Deputy Director-General, Public Health